Patients on mepolizumab, benralizumab, or dupilumab have diminished post-vaccination antibody and B cell responses to SARS-CoV-2.

EUROPEAN RESPIRATORY JOURNAL(2023)

引用 0|浏览7
暂无评分
关键词
Asthma. Immunology. Vaccination
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要